ABOUT OUR COMPANY

SAIL Fusion is an early-stage medical device company that has developed an novel, patented treatment for sacroiliac joint dysfunction. The device fuses the sacroiliac joint to address a common, and increasingly diagnosed cause of lower back pain. This system uses a novel, posterior mini-open approach for maximum joint preparation and graft delivery. The technique is built on the principles of the AO Foundation, which are the basis for all established orthopedic surgical techniques.

The SAIL Fusion system was inspired by a group of leading orthopedic and neuro surgeons. These ideas were incubated by a team of spinal industry veterans, who have developed some of the leading orthopedic products available today. Pending regulatory review and clearance, the SAIL Fusion system plans to build the future of sacroiliac treatment.

Surgery
 
Hospital Corridor

SI FUSION MARKET

With increasing clinical evidence identifying SI joint dysfunction as the cause of up to 30% of lower back pain, the SI joint fusion has seen outstanding year-over-year growth within the orthopedic medical device market with a CAGR of 19%. The global SI joint fusion market is estimated to reach USD 530M by 2027 thanks to both the rapidly increasing number of procedures, as well as the established reimbursement codes for minimally invasive and open SI joint fusion surgeries.¹²

 

SAIL FUSION TEAM

Square Standard_edited_edited.png

DAVID JANSEN

President

BenArnold_edited_edited.png

BEN ARNOLD

Director, Product Strategy

MichaelCollins_edited.png

MICHAEL COLLINS

Director, Market Development

BrianBowman_edited.png

BRIAN BOWMAN

Director, Engineering

SteveSpring_edited.png

STEVE SPRING

Business Development Manager

 
No upcoming events at the moment
 

¹ Global Info Research, (2020, August) Global MIS Sacroiliac Joint Fusion Sales Market Report 2020

² Orthopedic Network News, Vol 30, No 4, October 2019